George Kemble, Executive Chairman at Sagimet Biosciences Inc. (SGMT), sold 47,250 shares at $3.17 ($150K) on 2024-07-23, disclosed to the SEC on 2024-07-25.
Scheduled sale ($150k) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.17 | 23,625 | $75K | 50.0% |
| 2 | $3.17 | 23,625 | $75K | 50.0% |
| Total | $3.17 avg | 47,250 | $150K | 100% |
| Filing → |
| SGMT | SELL | 2026-07-22 | $141K | — | Filing → |
| SGMT | SELL | 2025-11-21 | $580K | — | Filing → |
| SGMT | SELL | 2024-07-23 | $44K | — | Filing → |